ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,229.98
0.04%
US Tech 100
22,072.00
-0.79%
Dow Jones
44,406.36
-0.94%
Brent Oil
68.885
-0.55%
Bitcoin
108,348.00
0.03%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Channel Therapeutics Corporation (CHRO) Quote

Channel Therapeutics Corporation

Channel Therapeutics Corporation (CHRO)

AMEX
13.50
0.00
(0.00%)
Closed July 08 4:00PM
15 min delayed - Upgrade to Realtime
0.00
0.00
(0.00%)
After Hours: -
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
13.50
( - )
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
4.50 52 Week Range 38.00
Market Cap
89.044M
Previous Close
13.50
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
820,224
Shares Outstanding
6,595,850
Dividend Yield
-
PE Ratio
-11.19
Earnings Per Share (EPS)
-1.21
Revenue
-
Net Profit
-7.96M

About Channel Therapeutics Corporation

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
channeltherapeutics.com
Headquarters
Reno, Nevada, USA
Founded
-
Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Channel Therapeutics was $13.50. Over the last year, Channel Therapeutics shares have traded in a share price range of $ 4.50 to $ 38.00.

Channel Therapeutics currently has 6,595,850 shares outstanding. The market capitalization of Channel Therapeutics is $89.04 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -11.19.

Ask ADVFN Intelligence (AI)

CHRO Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
5 hours ago
CHRO (0.00%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
5 hours ago
CHRO (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
July 02 2025
CHRO (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 18 2024
CHRO (0.00%)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Edgar (US Regulatory)
May 15 2024
CHRO (0.00%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 15 2024
CHRO (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.5-3.571428571431415.312.30112287112.95623764CS
41.916.379310344811.618.811.216420113.17895709CS
12-0.2-1.459854014613.723.7982022417.59373927CS
265.49768.68674247168.003387.98179964620.83616889CS
520.75.4687512.8384.544364519.27796051CS
156-46.5-77.560604.532608819.40998044CS
260-46.5-77.560604.532608819.40998044CS

CHRO - Frequently Asked Questions (FAQ)

What is the current Channel Therapeutics share price?
The current share price of Channel Therapeutics is $ 13.50
How many Channel Therapeutics shares are in issue?
Channel Therapeutics has 6,595,850 shares in issue
What is the market cap of Channel Therapeutics?
The market capitalisation of Channel Therapeutics is USD 89.04M
What is the 1 year trading range for Channel Therapeutics share price?
Channel Therapeutics has traded in the range of $ 4.50 to $ 38.00 during the past year
What is the PE ratio of Channel Therapeutics?
The price to earnings ratio of Channel Therapeutics is -11.19
What is the reporting currency for Channel Therapeutics?
Channel Therapeutics reports financial results in USD
What is the latest annual profit for Channel Therapeutics?
The latest annual profit of Channel Therapeutics is USD -7.96M
What is the registered address of Channel Therapeutics?
The registered address for Channel Therapeutics is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
What is the Channel Therapeutics website address?
The website address for Channel Therapeutics is channeltherapeutics.com
Which industry sector does Channel Therapeutics operate in?
Channel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LGPSLogProstyle Inc
$ 1.6902
(101.21%)
71.92M
NAKNorthern Dynasty Minerals Ltd
$ 1.7916
(27.97%)
33.58M
KNWKnow Labs Inc
$ 3.01
(22.86%)
3M
SSYSunlink Health Systems
$ 1.03
(19.08%)
211.52k
MINFT Limited
$ 2.45
(17.79%)
87.51k
BMNRBitMine Immersion Technologies Inc
$ 107.0246
(-20.72%)
18.88M
TSLTT Rex 2X Long Tesla Daily Target ETF
$ 13.615
(-13.67%)
6.45M
EGGEnigmatig Limited
$ 4.92
(-13.38%)
492.91k
QUBXTradr 2X Long QUBT Daily ETF
$ 31.29
(-11.69%)
203.22k
ELONBattleshares Tsla vs F ETF
$ 11.01
(-11.49%)
9.76k
SOXSDirexion Daily Semiconductor Bear 3X Shares New
$ 7.87
(5.64%)
240.65M
DNNDenison Mines Corp
$ 1.8195
(-0.03%)
102.63M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 1.87
(13.33%)
97.41M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 24.97
(-5.52%)
93.3M
SPYSPDR S&P 500
$ 620.68
(-0.75%)
73.15M

CHRO Discussion

View Posts
81vette 81vette 2 weeks ago
CHRO ,merger with LGND(114.00) new separate ticker is for fda approved product going to mkt. https://www.ncbiotech.org/news/corporate-recombinations-include-50m-new-life-durhams-pelthos
👍️0
81vette 81vette 2 weeks ago
Loading 1.15/1.16 so far,zero borrow now,merger new ticker r/s with Pelthos at close Monday 6-30,I will be selling before close ,could have a run but very risky,trade accordingly (the only good split is a banana split
👍️0
Monksdream Monksdream 3 months ago
CHRO,under $2
👍️0
makinezmoney makinezmoney 3 months ago
$CHRO: Merging with Ligands' Pelthos..........


https://finance.yahoo.com/news/ligand-subsidiary-pelthos-therapeutics-combine-100000828.html

Channel Therapeutics Corporation - $CHRO - 🇺🇸

Sector: Healthcare - Biotechnology
Market Cap: 7.66M
Float: 1.24M

News: Ligand Pharmaceuticals’ subsidiary, Pelthos Therapeutics, will merge with Channel Therapeutics in a $50M equity deal to form Pelthos Therapeutics Inc., trading on NYSE American as PTHS. Ligand will invest $18M, retaining a 13% royalty on ZELSUVMI™, an FDA-approved topical gel for molluscum contagiosum, the first at-home prescription therapy. Led by Pelthos CEO Scott Plesha and Channel’s CFO Frank Knuettel, the company will commercialize ZELSUVMI and advance Channel’s NaV 1.7 non-opioid pain treatments. The $32M deal, backed by a Murchinson-led group, will close in summer 2025. Molluscum contagiosum, a contagious skin infection, affects 16.7M in the U.S.

GO $CHRO
👍️0
makinezmoney makinezmoney 3 months ago
$CHRO: BOooommmmmmm........... Bagger now $2.10

There it goes........... Mega POP.

Only $1.25 yesterday and there she goes.


GO $CHRO
👍️0
glenn1919 glenn1919 5 months ago
CHRO.........................https://stockcharts.com/h-sc/ui?s=CHRO&p=W&b=5&g=0&id=p86431144783
👍️0
Invest-in-America Invest-in-America 6 months ago
CHRO: Whelp, looks like we can all thank iHub's Colonel GLENN, on THAT note now, Homeboy.
👍️0
tw0122 tw0122 6 months ago
$3.08 + 60% Meant to tell you a Friday when still in $1s to
Open board but you got it done 
👍️0
Invest-in-America Invest-in-America 6 months ago
CHRO: Micro-FLoat, NO-BRAINER!!
👍️0
Invest-in-America Invest-in-America 6 months ago
CHRO: WOW!!
👍️0
glenn1919 glenn1919 6 months ago
CHRO............................https://stockcharts.com/h-sc/ui?s=CHRO&p=W&b=5&g=0&id=p86431144783
👍️0

Your Recent History

AMEX
CHRO
Channel Therapeutics
Delayed Upgrade Clock
ADVFN
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads